Loading...
Header Logo
Keywords
Last Name
Institution

KEVIN FURMAN ERICKSON

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
DivisionMedicine-Nephrology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Research 
    Collapse research activities and funding
    F32HS019178     (ERICKSON, KEVIN)Jul 1, 2010 - Jun 30, 2013
    AHRQ
    "G-code" Reimbursement and Outcomes in Hemodialysis
    Role: Principal Investigator

    K23DK101693     (ERICKSON, KEVIN)Apr 1, 2014 - Jan 31, 2019
    NIH/NIDDK
    The Effect of Provider Market Competition on Patient Health Outcomes in Dialysis
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Erickson KF, Navaneethan SD. Bariatric Surgery for ESKD Patients: Why, When, and How? Clin J Am Soc Nephrol. 2019 Aug 07; 14(8):1125-1127. PMID: 31345841.
      View in: PubMed
    2. Shen JI, Erickson KF, Chen L, Vangala S, Leng L, Shah A, Saxena AB, Perl J, Norris KC. Expanded Prospective Payment System and Use of and Outcomes with Home Dialysis by Race and Ethnicity in the United States. Clin J Am Soc Nephrol. 2019 Aug 07; 14(8):1200-1212. PMID: 31320318.
      View in: PubMed
    3. Zuber K, Davis J, Erickson KF. Nephrology Advanced Practitioners in the United States, 2010-2018. Clin J Am Soc Nephrol. 2019 Jul 11. PMID: 31296504.
      View in: PubMed
    4. Walther CP, Erickson KF. The cost-effectiveness of lipid lowering for primary cardiovascular prevention in chronic kidney disease: moving beyond statins. Kidney Int. 2019 Jul; 96(1):22-25. PMID: 31229030.
      View in: PubMed
    5. Erickson KF, Zhao B, Niu J, Winkelmayer WC, Bhattacharya J, Chertow GM, Ho V. Association of Hospitalization and Mortality Among Patients Initiating Dialysis With Hemodialysis Facility Ownership and Acquisitions. JAMA Netw Open. 2019 May 03; 2(5):e193987. PMID: 31099872.
      View in: PubMed
    6. Anumudu S, Airy M, Erickson KF, Navaneethan SD, Chang TI, Winkelmayer WC, Niu J. Predialysis Nephrology Care and Incident Atrial Fibrillation in Older Patients With ESKD Initiating Dialysis. Kidney Int Rep. 2019 May; 4(5):679-687. PMID: 31080923.
      View in: PubMed
    7. Brady BM, Erickson KF. Integrated Care in ESKD: A Perspective of Nephrologists. Clin J Am Soc Nephrol. 2019 Mar 07; 14(3):451-453. PMID: 30696662.
      View in: PubMed
    8. Erickson KF, Ho V, Winkelmayer WC. Did Medicaid Expansion Reduce Mortality Among Patients Initiating Dialysis for Irreversible Kidney Failure? JAMA. 2018 12 04; 320(21):2206-2208. PMID: 30422240.
      View in: PubMed
    9. Awan AA, Niu J, Pan JS, Erickson KF, Mandayam S, Winkelmayer WC, Navaneethan SD, Ramanathan V. Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014). Am J Nephrol. 2018; 48(6):472-481. PMID: 30472701.
      View in: PubMed
    10. Erickson KF, Winkelmayer WC. Evaluating the Evidence behind Policy Mandates in US Dialysis Care. J Am Soc Nephrol. 2018 Dec; 29(12):2777-2779. PMID: 30389727.
      View in: PubMed
    11. Lin E, Mell MW, Winkelmayer WC, Erickson KF. Health Insurance in the First 3 Months of Hemodialysis and Early Vascular Access. Clin J Am Soc Nephrol. 2018 Dec 07; 13(12):1866-1875. PMID: 30385594.
      View in: PubMed
    12. Brady BM, Zhao B, Niu J, Winkelmayer WC, Milstein A, Chertow GM, Erickson KF. Patient-Reported Experiences of Dialysis Care Within a National Pay-for-Performance System. JAMA Intern Med. 2018 Oct 01; 178(10):1358-1367. PMID: 30208398.
      View in: PubMed
    13. Awan AA, Thomas SS, Erickson KF. Making Policy in the Dark: The Use of Activated Vitamin D Under Bundled Payments for Dialysis Care. Am J Kidney Dis. 2018 Aug; 72(2):161-163. PMID: 30037474.
      View in: PubMed
    14. Erickson KF, Winkelmayer WC, Ho V, Bhattacharya J, Chertow GM. Market Consolidation and Mortality in Patients Initiating Hemodialysis. Value Health. 2019 01; 22(1):69-76. PMID: 30661636.
      View in: PubMed
    15. Erickson KF, Qureshi S, Winkelmayer WC. The Role of Big Data in the Development and Evaluation of US Dialysis Care. Am J Kidney Dis. 2018 Oct; 72(4):560-568. PMID: 29921451.
      View in: PubMed
    16. Erickson KF, Zheng Y, Ho V, Winkelmayer WC, Bhattacharya J, Chertow GM. Market Competition and Health Outcomes in Hemodialysis. Health Serv Res. 2018 10; 53(5):3680-3703. PMID: 29468675.
      View in: PubMed
    17. Erickson KF, Zhao B, Ho V, Winkelmayer WC. Employment among Patients Starting Dialysis in the United States. Clin J Am Soc Nephrol. 2018 02 07; 13(2):265-273. PMID: 29348264.
      View in: PubMed
    18. Perez JJ, Zhao B, Qureshi S, Winkelmayer WC, Erickson KF. Health Insurance and the Use of Peritoneal Dialysis in the United States. Am J Kidney Dis. 2018 04; 71(4):479-487. PMID: 29277511.
      View in: PubMed
    19. Qureshi S, Erickson KF, Winkelmayer WC. A Case for More Frequent, Not Just Earlier, Nephrology Care of Patients Approaching ESRD? Am J Kidney Dis. 2017 08; 70(2):155-157. PMID: 28739124.
      View in: PubMed
    20. Shen JI, Dave NN, Erickson KF. Home Alone: Does Modality Matter? Revisiting Hospital Readmissions in Dialysis. Am J Kidney Dis. 2017 07; 70(1):1-3. PMID: 28646981.
      View in: PubMed
    21. Erickson KF, Winkelmayer WC, Chertow GM, Bhattacharya J. Hemodialysis Hospitalizations and Readmissions: The Effects of Payment Reform. Am J Kidney Dis. 2017 Feb; 69(2):237-246. PMID: 27856087.
      View in: PubMed
    22. Erickson KF, Zheng Y, Winkelmayer WC, Ho V, Bhattacharya J, Chertow GM. Consolidation in the Dialysis Industry, Patient Choice, and Local Market Competition. Clin J Am Soc Nephrol. 2017 Mar 07; 12(3):536-545. PMID: 27831510.
      View in: PubMed
    23. Erickson KF, Winkelmayer WC, Chertow GM, Bhattacharya J. Effects of physician payment reform on provision of home dialysis. Am J Manag Care. 2016 06 01; 22(6):e215-23. PMID: 27355909.
      View in: PubMed
    24. Mendu ML, Erickson KF, Hostetter TH, Winkelmayer WC, Olan G, Meyer RN, Hakim R, Sedor JR. Federal Funding for Kidney Disease Research: A Missed Opportunity. Am J Public Health. 2016 Mar; 106(3):406-7. PMID: 26885959.
      View in: PubMed
    25. O'Shaughnessy MM, Erickson KF. Measuring comorbidity in patients receiving dialysis: can we do better? Am J Kidney Dis. 2015 Nov; 66(5):731-4. PMID: 26210068.
      View in: PubMed
    26. Erickson KF, Kurella Tamura M. Overlooked care transitions: an opportunity to reduce acute care use in ESRD. Clin J Am Soc Nephrol. 2015 Mar 06; 10(3):347-9. PMID: 25649156.
      View in: PubMed
    27. Erickson KF, Mell MW, Winkelmayer WC, Chertow GM, Bhattacharya J. Provider visit frequency and vascular access interventions in hemodialysis. Clin J Am Soc Nephrol. 2015 Feb 06; 10(2):269-77. PMID: 25587105.
      View in: PubMed
    28. Erickson KF, Mell M, Winkelmayer WC, Chertow GM, Bhattacharya J. Provider Visits and Early Vascular Access Placement in Maintenance Hemodialysis. J Am Soc Nephrol. 2015 Aug; 26(8):1990-7. PMID: 25452668.
      View in: PubMed
    29. Erickson KF, Winkelmayer WC, Chertow GM, Bhattacharya J. Physician visits and 30-day hospital readmissions in patients receiving hemodialysis. J Am Soc Nephrol. 2014 Sep; 25(9):2079-87. PMID: 24812168.
      View in: PubMed
    30. Shen JI, Montez-Rath ME, Mitani AA, Erickson KF, Winkelmayer WC. Correlates and variance decomposition analysis of heparin dosing for maintenance hemodialysis in older US patients. Pharmacoepidemiol Drug Saf. 2014 May; 23(5):515-25. PMID: 24677688.
      View in: PubMed
    31. Erickson KF, Chertow GM, Goldhaber-Fiebert JD. Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Ann Intern Med. 2014 Jan 21; 160(2):143. PMID: 24445704.
      View in: PubMed
    32. Erickson KF, Winkelmayer WC, Chertow GM, Bhattacharya J. Medicare Reimbursement Reform for Provider Visits and Health Outcomes in Patients on Hemodialysis. Forum Health Econ Policy. 2014 Jan 01; 17(1):53-77. PMID: 26180520.
      View in: PubMed
    33. Erickson KF, Chertow GM, Goldhaber-Fiebert JD. Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Ann Intern Med. 2013 Sep 17; 159(6):382-9. PMID: 24042366.
      View in: PubMed
    34. Erickson KF, Japa S, Owens DK, Chertow GM, Garber AM, Goldhaber-Fiebert JD. Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. J Am Coll Cardiol. 2013 Mar 26; 61(12):1250-8. PMID: 23500327.
      View in: PubMed
    35. Erickson KF, Tan KB, Winkelmayer WC, Chertow GM, Bhattacharya J. Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations. Clin J Am Soc Nephrol. 2013 Jun; 8(6):987-94. PMID: 23430207.
      View in: PubMed
    36. Erickson KF, Lea J, McClellan WM. Interaction between GFR and risk factors for morbidity and mortality in African Americans with CKD. Clin J Am Soc Nephrol. 2013 Jan; 8(1):75-81. PMID: 23085727.
      View in: PubMed
    37. Kanda E, Erickson K, Bond TC, Krisher J, McClellan WM. Hemodialysis treatment center early mortality rates for incident hemodialysis patients are associated with the quality of care prior to starting but not following onset of dialysis. Am J Nephrol. 2011; 33(5):390-7. PMID: 21464568.
      View in: PubMed
    38. Erickson KF, Winkelmayer WC. The challenges of cost-effectiveness analyses for the clinician. Am J Kidney Dis. 2010 Dec; 56(6):1023-5. PMID: 21094913.
      View in: PubMed
    ERICKSON's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description